The Weight-Loss Drug Frenzy Is Outrunning the Company Behind It

Ozempic and Wegovy have propelled Novo Nordisk to Europe’s second-most valuable company. Now it faces a struggle to keep up #press

https://www.bloomberg.com/news/features/2023-08-08/ozempic-wegovy-despite-reported-side-effects-drugs-famed-for-weight-loss?utm_source=press.coop